<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00729976</url>
  </required_header>
  <id_info>
    <org_study_id>091/08</org_study_id>
    <nct_id>NCT00729976</nct_id>
  </id_info>
  <brief_title>Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.</brief_title>
  <official_title>Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fever is one of the most common symptoms in pediatrics and one of the most common reasons for
      visits in pediatricians' office and pediatric emergency departments. Many parents consider
      fever to be the most terrifying symptom.

      Ibuprofen is an effective and safe treatment for febrile children. Until recently ibuprofen
      was available only in tablets suspension and as a liquid gel. All these dosage form are
      administered orally. Rectal suppositories are often essential for treating febrile children
      who cannot take medications by mouth (e.g vomiting). In the current study we aim to compare
      the effect on fever of ibuprofen given as suspension with ibuprofen suppositories.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal change in temperature during the 4-hour period after enrollment.</measure>
    <time_frame>4 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with a drop of at least 1°C and 2°C in mean temperature at 4h. Decrement in fever at each time point, and the area under the temperature (versus time) curve. Proportion of patients with temperature &lt; 38 at 4 hours.</measure>
    <time_frame>4 h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Fever</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ibuprofen Suppository</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen suspension</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen suppository</intervention_name>
    <description>5-10mg/Kg of ibuprofen</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen Suspension</intervention_name>
    <description>5-10mg/Kg</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age: 3 mo- 4 years

          -  Weight 6 - 18 kg

          -  Rectal temperature &gt; 38.50

        Exclusion Criteria:

          -  Treatment with acetaminophen in the last 4 hours

          -  Treatment with Ibuprofen in the last 6 hours

          -  Unable to take oral or rectal medications

          -  Hypersensitivity to ibuprofen

          -  Renal failure

          -  Liver disease

          -  Rectal temperature can't be measured (due to anatomical or medical problem)

          -  Informed consent could not be granted
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eran Kozer, MD</last_name>
    <phone>972 8 9779916</phone>
    <email>erank@asaf.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ehud Rosenbloom, MD</last_name>
    <phone>972 8 9779916</phone>
    <email>ehudroze@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assaf Harofeh Medical Center</name>
      <address>
        <city>Zerifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eran Kozer, MD</last_name>
      <phone>97289779916</phone>
      <email>erank@asaf.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2008</study_first_submitted>
  <study_first_submitted_qc>August 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2008</study_first_posted>
  <last_update_submitted>April 4, 2011</last_update_submitted>
  <last_update_submitted_qc>April 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Eran Kozer</name_title>
    <organization>Assaf-Harofeh Medical Center</organization>
  </responsible_party>
  <keyword>Ibuprofen</keyword>
  <keyword>Suppository</keyword>
  <keyword>febrile children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

